Documentos relacionados

1. Serotype-specific quantification of residual free polysaccharide in multivalent pneumococcal conjugate vaccines.
2. Distinct baseline immune characteristics associated with responses to conjugated and unconjugated pneumococcal polysaccharide vaccines in older adults.
3. Post-13-Valent Pneumococcal Conjugate Vaccine Dynamics in Young Children.
4. Comparing the Impact of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease.
5. Reply to Theilacker et al.
6. Prevention of Pneumococcal Infections in Adults Using Conjugate Vaccines: No Easy Answers.
7. Baseline immune characteristics linked to pneumococcal vaccine responsiveness in older adults.
8. The Pneumococcal Polysaccharide-Tetanus Toxin Native C-Fragment Conjugate Vaccine: The Carrier Effect and Immunogenicity.
9. [The surveillance analysis of the adverse events following immunization of the domestic 13-valent pneumococcal polysaccharide conjugate vaccine in Zhejiang Province].
10. Weather factors, PCV intervention and childhood pneumonia in rural Bangladesh.